mvdln schreef op 3 mei 2021 16:58:
Intussen tweet Dirk Haussecker er weer mooi op los over ARWR (negatief?):
Multivalent Dirk Haussecker
@RNAiAnalyst
$AFMD has more solid + commercially more immediately relevant clinical data at $1B market cap than $ARWR did when they reached their 1st $1B MC*.
Discuss.
* dare I say, $AFMD will be commercial before $ARWR.